Learn more about our Diagnostics work.
WASHINGTON, D.C. –New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 190 million. A breakdown of the data shows…
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 180 million. A breakdown of the data shows…
“Game-changing” testing innovation from Quidel will save lives heading into flu season WASHINGTON, D.C. – AdvaMed® released the following statements on the announcement last night that Quidel Corporation, a member company of AdvaMed®…
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 160 million. A breakdown of the data shows…
100-million-plus antigen tests to be shipped by end of fall WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement: “AdvaMed® fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement:
Read background information on how AdvaMedDx®’s members produce IVD tests to detect COVID-19.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…